Hyaluronic acid fillers and botulinum toxin type A: Rationale for their individual and combined use for injectable facial rejuvenation

Plastic and Reconstructive Surgery

Volumn 120, Issue 6 S SUPPL., 2007, Pages

  Klein, Arnold W ^a   Fagien, Steven ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; FILLER; HYALURONIC ACID;

ARTICLE; ESTHETIC SURGERY; EXPERIENCE; FACE SURGERY; FOOD AND DRUG ADMINISTRATION; HUMAN; INJECTION; PRIORITY JOURNAL; REJUVENATION; UNITED STATES;

ADULT; BOTULINUM TOXINS; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; FACE; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; MIDDLE AGED; REJUVENATION;

EID: 37348998912     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000248857.84859.07     Document Type: Article

References (22)

1. Carruthers, J. D., Lowe, N. J., Menter, M. A., Gibson, J., and Eadie, N. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type a for patients with glabellar lines. Plast. Reconstr. Surg. 112: 21S, 2003.
2. Ascher, B., Zakine, B., Kestemont, P., Baspeyras, M., Bougara, A., and Santini, J. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J. Am. Acad. Dermatol. 51: 223, 2004.
3. Spiegel, J. H. Treatment of periorbital rhytids with botulinum toxin type A: Maximizing safety and results. Arch. Facial Plast. Surg. 7: 198, 2005.
4. DeLustro, F., Condell, R. A., Nguyen, M., et al. A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen. J. Biomed. Mater. Res. 20: 109, 1986.
5. Klein, A. W., and Rish, D. C. Injectable collagen: An adjunct to facial plastic surgery. Facial Plast. Surg. 4: 87, 1987.
6. Biomatrix, Inc. Data on file. Ridgefield, N.J.: Biomatrix, Inc.
7. Richter, W. Non-immunogenicity of purified hyaluronic acid preparations tested by passive cutaneous anaphylaxis. Int. Arch. Allergy Appl. Immunol. 47: 211, 1974.
8. Richter, W., Ryde, E., and Zetterstrom, E. O. Non-immunogenicity of purified sodium hyaluronate preparations in man. Int. Arch. Allergy Appl. Immunol. 59: 45, 1979.
9. Friedman, P., Mafong, E. A., Kauver, A. N., and Geronemus, R. G. Safety data of injectable non-animal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol. Surg. 28: 491, 2002.
10. Piacquadio, D. J., Larsen, N. E., Denlinger, J. L., et al. Hylan B gel (Hylaform) as a soft tissue augmentation material. In A. W. Klein (Ed.), Tissue Augmentation in Clinical Practice: Procedures and Techniques. New York: Marcel Dekker, 1998. Pp. 271-275.
11. Lowe, N. J., Maxwell, C. A., Lowe, P., et al. Hylauronic acid skin fillers: Adverse reactions and skin testing. J. Am. Acad. Dermatol. 45: 930, 2001.
12. Schanz, S., Schippert, W., Ulmer, A., Rassner, G., and Fierlbeck, G. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br. J. Dermatol. 146: 928, 2002.
13. Waddell, D. D. Acute reaction to intra-articular Hylan G-F. J. Bone Joint Surg. (Am.) 85: 1620, 2003.
14. Duranti, F., Salti, G., Bovani, B., et al. Injectable hyaluronic acid gel for soft tissue augmentation: A clinical and histological study. Dermatol. Surg. 24: 1317, 1998.
15. Cantisano-Zilkha, M., and Bosniak, S. Hyaluronic acid gel injections for facial rejuvenation: A 3-year clinical experience. Oper. Techn. Oculoplast. Orbital Reconstr. Surg. 2: 177, 1999.
16. Olenius, M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles and folds. Aesthetic Plast. Surg. 22: 97, 1998.
17. Canadian Consensus Report Proceedings of the North American long-term assessment of the use of injectable Artecoll by specialist physicians, October 15, 2002.
18. Micheels, P. Human anti-hyaluronic acid antibodies: Is it possible? Dermatol. Surg. 27: 185, 2001.
19. Report to FDA General and Plastic Surgery Device Panel, November 21, 2003.
20. Lupton, J. R., and Alsters, T. S. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol. Surg. 26: 135, 2000.
21. Brody, H. J. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol. Surg. 31: 893, 2005.
22. Fagien, S., and Rohrich, R. J. Combining botulinum toxin type A and the new generation of hyaluronic acid fillers. Teaching course at the Annual Meeting of the American Society of Plastic Surgeons, October 2004 and September 2005.